Absci | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Absci is a data-first AI drug creation company that focuses on designing differentiated therapeutics using generative AI. The company...
Absci is a data-first AI drug creation company that focuses on designing differentiated therapeutics using generative AI. The company utilizes its Integrated Drug Creation platform to develop advanced AI models for drug discovery, particularly targeting difficult-to-drug biologics. Headquartered in Vancouver, Washington, Absci aims to unlock novel biology and enhance the therapeutic potential of proteins through innovative technologies.
Website
Headquarters
Vancouver, Washington
Size
51-200 employees
Industry
Biotechnology Research
Specialities
generative AI, synthetic biology, biologics, drug discovery, antibody development, artificial intelligence, pharmaceuticals, biotechnology
🛍️ Absci Product and Pricing News →
👔 Absci CEO, Management and Leadership Team →
⚔️ Absci Alternatives and Competitors →
💼 Absci Hiring and Layoffs →
🤖 Absci Developer, Integration and Automation News →
📈 Absci Financials, Fundraising and Valuation News →
🛍️ Absci Product and Pricing News
- Absci will present at the Festival of Biologics on April 23 in the AI and Machine Learning for Drug Discovery track.
👔 Absci CEO, Management and Leadership Team
-
Founder & CEO
-
Chief Financial Officer & Chief Business Officer
[email protected]
⚔️ Absci Alternatives and Competitors
- Global Blue Group |
- Stagwell |
- Phreesia |
- Sezzle |
- Ibotta |
- NeoGenomics |
- LegalZoom.com |
- Upbound Group |
- Applied Digital |
- Donnelley Financial Solutions |
- Generate Biomedicines |
- Ambrx |
- BigHat Biosciences |
- Cingulate |
- Vigil Neuroscience |
- HilleVax |
- Sibylla Biotech |
- Text IQ |
- Predictive Technology Group |
- OM1 |
- Albert.ai |
- Catalent Inc. |
- Exscientia |
- Relay |
- AbCellera
💼 Absci Hiring and Layoffs
- Absci is currently hiring for the position of Director, Alliance & Growth Strategy in the United States.
- Absci is seeking an experienced accounting leader as it approaches becoming a clinical-stage biotech, according to Todd Bedrick, SVP Chief Accounting Officer.
🤖 Absci Developer, Integration and Automation News
📈 Absci Financials, Fundraising and Valuation News
People also viewed
- GenBio AI |
- Archon Biosciences |
- Monod Bio |
- Menten AI |
- Nabla Bio |
- Generate Biomedicines |
- Profluent |
- Arzeda
